StonvexLoading…
StonvexStonvexStonvexCore line items from BYRN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-02-28 | Annual 2025 2025-11-30 | Q3 2025 2025-08-31 | Q2 2025 2025-05-31 |
|---|---|---|---|---|
Revenue | $29.05M | $118.12M | $82.87M | $54.70M |
Operating Income | $928.00K | $11.84M | $7.88M | $5.02M |
Net Income | $801.00K | $9.69M | $6.32M | $4.09M |
EPS (Diluted) | $0.03 | $0.40 | $0.26 | $0.17 |
Total Assets | $79.90M | $84.49M | $78.56M | Not available |
Total Liabilities | $13.41M | $18.73M | $15.42M | Not available |
Cash & Equivalents | $7.45M | $13.73M | $6.50M | Not available |
Free Cash Flow OCF − CapEx | $-5.04M | $-9.20M | $-17.33M | $-12.82M |
Shares Outstanding | 22.68M | 22.68M | 22.69M | 24.02M |